Newcastle upon Tyne, United Kingdom

Lauren Molyneux

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lauren Molyneux. Retrieved from https://idiyas.com/inventor/lauren-molyneux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lauren Molyneux: Innovator in Cancer Treatment

Introduction

Lauren Molyneux is a prominent inventor based in Newcastle upon Tyne, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific disease states.

Latest Patents

Lauren holds a patent for "Pyrrolcarboxamide derivatives for the inhibition of ERK5." This invention provides compounds of formula (I) or a tautomer, stereoisomer, N-oxide, pharmaceutically acceptable salt, or solvate thereof. The compounds are particularly useful for the prophylaxis or treatment of diseases mediated by ERK5, with a focus on cancers.

Career Highlights

Throughout her career, Lauren has demonstrated a commitment to advancing medical science through her innovative research. Her work has the potential to impact the treatment of various cancers, showcasing her dedication to improving patient outcomes.

Collaborations

Lauren has collaborated with notable colleagues, including Tristan Reuillon and Duncan Charles Miller. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Lauren Molyneux is a trailblazer in the field of cancer treatment, with her innovative patent paving the way for future advancements in medicinal chemistry. Her contributions are invaluable to the scientific community and hold promise for improving therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…